Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.62 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.50 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA7 | P43166 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.46 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.44 |
| ▸ | GRIN2A | Q12879 | 3/20 | 0.44 |
| ▸ | BCHE | P06276 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29364891 | 1.00 | IDO1 (0.62) | IDO1TAAR1CHRM2ABCB1CHRM1 | |
| SCHEMBL26654 | 0.89 | IDO1 (0.69) | IDO1TAAR1CHRM2ABCB1CHRM1 | |
| SCHEMBL16269056 | 0.83 | IDO1 (0.62) | IDO1TAAR1CHRM2ABCB1CHRM1 | |
| SCHEMBL5570300 | 0.82 | ABCB1 (0.53) | ABCB1ALDH1A1GAAMAPTCA1 | |
| SCHEMBL648250 | 0.82 | IDO1 (0.39) | IDO1ALDH1A1GAAMAPTL3MBTL1 | |
| SCHEMBL4661995 | 0.82 | IDO1 (0.60) | IDO1TAAR1CHRM2ABCB1CHRM1 | |
| SCHEMBL3166142 | 0.82 | IDO1 (0.60) | IDO1TAAR1CHRM2ABCB1CHRM1 | |
| SCHEMBL28384840 | 0.82 | IDO1 (0.66) | IDO1TAAR1CHRM2ABCB1CHRM1 | |
| SCHEMBL12949882 | 0.81 | IDO1 (0.42) | IDO1TAAR1CHRM2CHRM1ALDH1A1 | |
| SCHEMBL31290863 | 0.80 | IDO1 (0.69) | IDO1TAAR1CHRM2ABCB1CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250302678-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2025-10-02 | — | — | US | claimed |
| US-12350136-B2 | Absorbent articles including perfume and cyclodextrins | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-08 | — | — | US | claimed |
| WO-2025119493-A1 | PROBIOTICS FOR CAT LITTER | SYMRISE AG (DE) | 2025-06-12 | — | — | WO | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| US-20220401275-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2022-12-22 | — | — | US | claimed |
| US-11458049-B2 | Absorbent articles including perfume and cyclodextrins | THE PROCTER & GAMBLE COMPANY (US) | 2022-10-04 | — | — | US | claimed |
| EP-3509647-B1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2020-10-21 | — | — | EP | claimed |
| EP-3509647-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | The Procter and Gamble Company (US) | 2019-07-17 | — | — | EP | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| WO-2018048852-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | THE PROCTER & GAMBLE COMPANY (US) | 2018-03-15 | — | — | WO | claimed |
| US-20180064588-A1 | Absorbent Articles Including Perfume and Cyclodextrins | THE PROCTER & GAMBLE COMPANY | 2018-03-08 | — | — | US | claimed |
| EP-2072083-B1 | Utilisation of 2.4'-dimethyl-propiophenon as an aroma | SYMRISE AG (DE) | 2012-02-15 | — | — | EP | claimed |
| US-20090162308-A1 | USE OF 2,4'-DIMETHYLPROPIOPHENONE AS A FRAGRANCE SUBSTANCE | SYMRISE GMBH & CO. KG (DE) | 2009-06-25 | — | — | US | claimed |
| EP-2072083-A1 | Utilisation of 2.4'-dimethyl-propiophenon as an aroma | Symrise GmbH & Co. KG (DE) | 2009-06-24 | — | — | EP | claimed |
| US-20060166857-A1 | 4,8-Dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one used as perfumes | SYMRISE GMBH & CO. KG (DE) | 2006-07-27 | — | — | US | claimed |
| US-20260102294-A1 | ABSORBENT ARTICLE COMPRISING A FRAGRANCE AND AN ODOR CONTROL COMPOSITION | PROCTER & GAMBLE (US) | 2026-04-16 | — | — | US | disclosed |
| US-12577511-B2 | Agent containing emulsifier and microcapsules | HENKEL AG & CO. KGAA (DE) | 2026-03-17 | — | — | US | disclosed |
| WO-2006068276-A1 | HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR | SHOWA DENKO K.K. (JP) | 2006-06-29 | — | — | WO | disclosed |
| CN-1732019-A | Deodorant composition | TAKASAGO PERFUMERY CO LTD (JP) | 2006-02-08 | — | — | CN | disclosed |
| EP-1561476-A1 | DEODORANT COMPOSITION | Takasago International Corporation (JP) | 2005-08-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090162308-A1 | USE OF 2,4'-DIMETHYLPROPIOPHENONE AS A FRAGRANCE SUBSTANCE | CYP1B1, CYP4A22, ROS1 | IDO1 3818/4885TAAR1 2219/4885CHRM2 2637/4885 |
| US-12577511-B2 | Agent containing emulsifier and microcapsules | LIPA, CUTA, MGLL | IDO1 2210/4885TAAR1 2020/4885CHRM2 595/4885 |
| US-20260102294-A1 | ABSORBENT ARTICLE COMPRISING A FRAGRANCE AND AN ODOR CONTROL COMPOSITION | CUTA, SHBG, DSG1 | IDO1 3359/4885TAAR1 3564/4885CHRM2 878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.